Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MS&D develops subtype-selective 5-HT1D receptor agonists for migraine

Oct. 15, 1997

Preliminary human evaluation of DMP-543, a potential antidementia agent

Oct. 15, 1997

Role for NGF in Alzheimer's disease?

Oct. 14, 1997

Pierre Fabre discloses potent and selective 5-HT1B receptor antagonists

Oct. 14, 1997

Briana Bio-Tech licenses peptide technology for chronic MS

Oct. 13, 1997

Preclinical data indicate effectiveness of Sertoli cells in neural regeneration

Oct. 13, 1997

Important NRC discovery related to stroke and epilepsy

Oct. 10, 1997

VA-045 effective against TBI-induced retrograde and anterograde amnesia

Oct. 10, 1997

Scios/Wyeth-Ayerst commence large pivotal trials of bFGF for stroke

Oct. 10, 1997

Phase II results for ganaxolone in epilepsy and migraine anticipated by year-end

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...